| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |